+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • TechSci Research
  • ID: 5877585
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The IV Hydration Therapy Market was valued at USD 2.51 Billion in 2024, and is expected to reach USD 3.94 Billion by 2030, rising at a CAGR of 7.80%. This growth is primarily attributed to the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is also enhancing companies’ geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable to consume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health’s launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Dehydration-Related Conditions

The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According to the World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due to reduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy.

Key Market Challenges

Regulatory and Safety Concerns

IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research to establish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight to maintain patient safety and public trust.

Key Market Trends

Technological Advancements and Service Innovations

Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. Additionally, clinics are increasingly offering personalized IV solutions tailored to specific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments.

Key Market Players

  • Core IV Therapy, LLC
  • Cryojuvenate UK
  • B. Braun SE
  • Pfizer, Inc.
  • JW Life Science
  • Amanta Healthcare
  • Vifor Pharma Management Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • ICU Medical, Inc.

Report Scope:

In this report, the Global IV Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

  • Immune Booster
  • Energy Booster
  • Skin Care
  • Others

IV Hydration Therapy Market, By Component:

  • Emergency Healthcare
  • Routine Healthcare

IV Hydration Therapy Market, By End User:

  • Hospitals & Clinics
  • Wellness Centers & Spa
  • Home Healthcare
  • Others

IV Hydration Therapy Market, By Region:

  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global IV Hydration Therapy Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global IV Hydration Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Market Map
5.3.1 By Service
5.3.2 By Component
5.3.3 By End Users
5.3.4 By Region
6. North America IV Hydration Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
6.2.2. By Component (Emergency Healthcare, Routine Healthcare)
6.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States IV Hydration Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Component
6.3.1.2.3. By End User
6.3.2. Canada IV Hydration Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Component
6.3.2.2.3. By End User
6.3.3. Mexico IV Hydration Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Component
6.3.3.2.3. By End User
7. Europe IV Hydration Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
7.2.2. By Component (Emergency Healthcare, Routine Healthcare)
7.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France IV Hydration Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Component
7.3.1.2.3. By End User
7.3.2. Germany IV Hydration Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Component
7.3.2.2.3. By End User
7.3.3. United Kingdom IV Hydration Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Component
7.3.3.2.3. By End User
7.3.4. Italy IV Hydration Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Component
7.3.4.2.3. By End User
7.3.5. Spain IV Hydration Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Component
7.3.5.2.3. By End User
8. Asia-Pacific IV Hydration Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
8.2.2. By Component (Emergency Healthcare, Routine Healthcare)
8.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China IV Hydration Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Component
8.3.1.2.3. By End User
8.3.2. India IV Hydration Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Component
8.3.2.2.3. By End User
8.3.3. Japan IV Hydration Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Component
8.3.3.2.3. By End User
8.3.4. South Korea IV Hydration Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Component
8.3.4.2.3. By End User
8.3.5. Australia IV Hydration Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Component
8.3.5.2.3. By End User
9. South America IV Hydration Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
9.2.2. By Component (Emergency Healthcare, Routine Healthcare)
9.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil IV Hydration Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Component
9.3.1.2.3. By End User
9.3.2. Argentina IV Hydration Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Component
9.3.2.2.3. By End User
9.3.3. Colombia IV Hydration Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Component
9.3.3.2.3. By End User
10. Middle East and Africa IV Hydration Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
10.2.2. By Component (Emergency Healthcare, Routine Healthcare)
10.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa IV Hydration Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Component
10.3.1.2.3. By End User
10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Component
10.3.2.2.3. By End User
10.3.3. UAE IV Hydration Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Component
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global IV Hydration Therapy Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Core IV Therapy, LLC
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Cryojuvenate UK
15.3. B. Braun SE
15.4. Pfizer, Inc.
15.5. JW Life Science
15.6. Amanta Healthcare
15.7. Vifor Pharma Management Ltd
15.8. Otsuka Pharmaceutical Co., Ltd.
15.9. Baxter
15.10. ICU Medical, Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Core IV Therapy, LLC
  • Cryojuvenate UK
  • B. Braun SE
  • Pfizer, Inc.
  • JW Life Science
  • Amanta Healthcare
  • Vifor Pharma Management Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • ICU Medical, Inc.

Table Information